Literature DB >> 33769753

Cutaneous ulcer with thrombogenic vasculopathy in a patient receiving bevacizumab.

Aina Vila-Payeras1, María Iglesias-González2, Fernando Terrasa-Sagristá3, Elisabet Parera-Amer1.   

Abstract

Entities:  

Year:  2021        PMID： 33769753     DOI： 10.25259/IJDVL_398_20

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  4 in total

1.  Cutaneous Vasculopathy as an Adverse Effect of the Anti-Vascular Endothelial Growth Factor Agent Axitinib.

Authors:  Veronica J Shi; Anjela Galan; Ian D Odell; Jennifer N Choi
Journal:  JAMA Dermatol       Date:  2016-02       Impact factor: 10.282

2.  Ulceration of Striae distensae in high-grade glioma patients on concurrent systemic corticosteroid and bevacizumab therapy.

Authors:  Katherine B Peters; Thomas E Coyle; James J Vredenburgh; Annick Desjardins; Henry S Friedman; David A Reardon
Journal:  J Neurooncol       Date:  2010-06-04       Impact factor: 4.130

3.  Is bevacizumab a culprit of intractable skin ulcers?

Authors:  Naoya Murayama; Yuta Koike; Susumu Ikehara; Yumi Okubo; Saori Tomimura; Atsushi Utani
Journal:  J Dermatol       Date:  2016-03-06       Impact factor: 4.005

4.  Impaired wound healing and expansion of a large ulcer after bevacizumab with paclitaxel for skin metastases from breast cancer: report of a case.

Authors:  Yuko Kijima; Heiji Yoshinaka; Munetsugu Hirata; Akihiro Nakajo; Hideo Arima; Yoshiaki Shinden; Tetsuya Ijichi; Yuka Eguchi; Hiroshi Okumura; Yoshikazu Uenosono; Hiroshi Kurahara; Sumiya Ishigami; Shoji Natsugoe
Journal:  Surg Today       Date:  2014-05-16       Impact factor: 2.549
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.